Post-Launch Calibration Support for VIIRS Onboard NASA NPP Spacecraft

The NPP Instrument Calibration Support Element (NICSE) is one of the elements within the NASA NPP Science Data Segment (SDS). The primary responsibility of NICSE is to independently monitor and evaluate on-orbit radiometric and geometric performance of the Visible Infrared Imaging Radiometer Suite (VIIRS) instrument and to validate its Sensor Data Record (SDR) [1]. The NICSE interacts and works closely with other SDS Product Evaluation and Analysis Tools Elements (PEATE) and the NPP Science Team (ST) and supports their on-orbit data product calibration and validation efforts. The NICSE also works closely with the NPP Instrument Calibration Support Team (NICST) during sensor pre-launch testing in ambient and thermal vacuum environment [2]. This paper provides an overview of NICSE VIIRS sensor post-launch calibration support with a focus on the use of sensor on-board calibrators (OBC) for the radiometric calibration and characterization. It presents the current status of NICSE post-launch radiometric calibration tool development effort based on its design requirement

Multiyear On-orbit Calibration and Performance of Terra MODIS Thermal Emissive Bands

Since launch in December 1999, Terra MODIS has been making continuous Earth observations for more than seven years. It has produced a broad range of land, ocean, and atmospheric science data products for improvements in studies of global climate and environmental change. Among its 36 spectral bands, there are 20 reflective solar bands (RSB) and 16 thermal emissive bands (TEB). MODIS thermal emissive bands cover the mid-wave infrared (MWIR) and long-wave infrared (LWIR) spectral regions with wavelengths from 3.7 to 14.4pm. They are calibrated on-orbit using an on-board blackbody (BB) with its temperature measured by a set of thermistors on a scan-by-scan basis. This paper will provide a brief overview of MODIS TEB calibration and characterization methodologies and illustrate on-board BB functions and TEB performance over more than seven years of on-orbit operation and calibration. Discussions will be focused on TEB detector short-term stability and noise characterization, and changes in long-term response (or system gain). Results show that Terra MODIS BB operation has been extremely stable since launch. When operated at its nominal controlled temperature of 290K, the BB temperature variation is typically less than +0.30mK on a scan-by-scan basis and there has been no time-dependent temperature drift. In addition to excellent short-term stability, most TEB detectors continue to meet or exceed their specified noise characterization requirements, thus enabling calibration accuracy and science data product quality to be maintained. Excluding the noisy detectors identified pre-launch and those that occurred post-launch, the changes in TEB responses have been less than 0.7% on an annual basis. The optical leak corrections applied to bands 32-36 have been effective and stable over the entire missio

A Methodology to Assess the Impact of Optical and Electronic Crosstalk in a New Generation of Sensors Using Heritage Sensors

Electronic and optical crosstalk are radiometric challenges that often exist in the focal plane design in many sensors Such as MODIS. A methodology is described to assess the impact due to optical and electronic crosstalk on the measured radiance, and thereafter, the retrieval of geophysical products using MODIS Level I data sets. Based on a postulated set of electronic and optical crosstalk coefficients, and a set of MODIS scenes, we have simulated a system signal contamination on any detector on a focal plane when another detector on that focal plane is stimulated with a geophysical signal. The original MODIS scenes and the crosstalk impacted scenes can be used with validated geophysical algorithms to derive the final data products. Products contaminated with crosstalk are then compared to those without contamination to assess the impact magnitude and location, and will allow us to separate Out-Of-Band (OOB) leaks from hand-to-hand optical crosstalk, and identify potential failures to meet climate research requirements

Multidisciplinary Taiwan consensus for the use of conventional TACE in hepatocellular carcinoma treatment

Developed in early 1980s, transarterial chemoembolization (TACE) with Lipiodol was adopted globally after large-scale randomized control trials and meta-analyses proving its effectiveness were completed. Also known as “conventional TACE” (cTACE), TACE is currently the first-line treatment for patients with unresectable intermediate stage hepatocellular carcinoma (HCC) and delivers both ischemic and cytotoxic effects to targeted tumors. Although new technology and clinical studies have contributed to a more comprehensive understanding of when and how to apply this widely-adopted therapeutic modality, some of these new findings and techniques have yet to be incorporated into a guideline appropriate for Taiwan. In addition, differences in the underlying liver pathologies and treatment practices for transcatheter embolization between Taiwan and other Asian or Western populations have not been adequately addressed, with significant variations in the cTACE protocols adopted in different parts of the world. These mainly revolve around the amount and type of chemotherapeutic agents used, the type of embolic materials, reliance on Lipiodol, and the degree of selectiveness in catheter positioning. Subsequently, interpreting and comparing results obtained from different centers in a systematic fashion remain difficult, even for experienced practitioners. To address these concerns, we convened a panel of experts specializing in different aspects of HCC treatment to devise modernized recommendations that reflect recent clinical experiences, as well as cTACE protocols which are tailored for use in Taiwan. The conclusions of this expert panel are described herein

Temporal and Spatial Variations of Picoplankton and Nanoplankton and Short-Term Variability Related to Stormy Weather in the Danshui River Estuary in Northern Taiwan

This study examined the seasonal dynamics of the bacteria, Synechococcus spp. and their nanoflagellate grazers in the Danshui River estuary in northern Taiwan and compared the variations in microbes (bacteria, Synechococcus spp. and nanoflagellate) dynamics under different (clear vs. stormy) weather conditions. Temporal variations in chlorophyll a concentrations, bacterial production, bacteria and Synechococcus spp. abundance were related to temperature, with higher values during the warmer seasons. Spatial variations in Synechococcus spp. were related to chlorophyll a concentrations and in bacterial production and abundance related to chlorophyll a concentrations when temperature is above 20¢XC (April, August, and October). Spatial variations in nanoflagellates were related to oscillations in bacterial abundance or production during non-rainy periods. We conclude that heavy freshwater input to the estuary carries a large quantity of riverine bacteria which might disrupt the relationship between bacterial and nanoflagellate abundance during rainfall events

2015 Guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the Management of Hypertension

It has been almost 5 years since the publication of the 2010 hypertension guidelines of the Taiwan Society of Cardiology (TSOC). There is new evidence regarding the management of hypertension, including randomized controlled trials, non-randomized trials, post-hoc analyses, subgroup analyses, retrospective studies, cohort studies, and registries. More recently, the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC) published joint hypertension guidelines in 2013. The panel members who were appointed to the Eighth Joint National Committee (JNC) also published the 2014 JNC report. Blood pressure (BP) targets have been changed; in particular, such targets have been loosened in high risk patients. The Executive Board members of TSOC and the Taiwan Hypertension Society (THS) aimed to review updated information about the management of hypertension to publish an updated hypertension guideline in Taiwan. We recognized that hypertension is the most important risk factor for global disease burden. Management of hypertension is especially important in Asia where the prevalence rate grows faster than other parts of the world. In most countries in East Asia, stroke surpassed coronary heart disease (CHD) in causing premature death. A diagnostic algorithm was proposed, emphasizing the importance of home BP monitoring and ambulatory BP monitoring for better detection of night time hypertension, early morning hypertension, white-coat hypertension, and masked hypertension. We disagreed with the ESH/ESH joint hypertension guidelines suggestion to loosen BP targets to <140/90 mmHg for all patients. We strongly disagree with the suggestion by the 2014 JNC report to raise the BP target to <150/90 mmHg for patients between 60-80 years of age. For patients with diabetes, CHD, chronic kidney disease who have proteinuria, and those who are receiving antithrombotic therapy for stroke prevention, we propose BP targets of <130/80 mmHg in our guidelines. BP targets are <140/90 mmHg for all other patient groups, except for patients ≥80 years of age in whom a BP target of <150/90 mmHg would be optimal. For the management of hypertension, we proposed a treatment algorithm, starting with life style modification (LSM) including S-ABCDE (Sodium restriction, Alcohol limitation, Body weight reduction, Cigarette smoke cessation, Diet adaptation, and Exercise adoption). We emphasized a low-salt strategy instead of a no-salt strategy, and that excessively aggressive sodium restriction to <2.0 gram/day may be harmful. When drug therapy is considered, a strategy called “PROCEED” was suggested (Previous experience, Risk factors, Organ damage, Contraindications or unfavorable conditions, Expert's or doctor's judgment, Expenses or cost, and Delivery and compliance issue). To predict drug effects in lowering BP, we proposed the “Rule of 10” and “Rule of 5”. With a standard dose of any one of the 5 major classes of anti-hypertensive agents, one can anticipate approximately a 10-mmHg decrease in systolic BP (SBP) (Rule of 10) and a 5-mmHg decrease in diastolic BP (DBP) (Rule of 5). When doses of the same drug are doubled, there is only a 2-mmHg incremental decrease in SBP and a 1-mmHg incremental decrease in DBP. Preferably, when 2 drugs with different mechanisms are to be taken together, the decrease in BP is the sum of the decrease of the individual agents (approximately 20 mmHg in SBP and 10 mmHg in DBP). Early combination therapy, especially single-pill combination (SPC), is recommended. When patient's initial treatment cannot get BP to targeted goals, we have proposed an adjustment algorithm, “AT GOALs” (Adherence, Timing of administration, Greater doses, Other classes of drugs, Alternative combination or SPC, and LSM + Laboratory tests). Treatment of hypertension in special conditions, including treatment of resistant hypertension, hypertension in women, and perioperative management of hypertension, were also mentioned. The TSOC/THS hypertension guidelines provide the most updated information available in the management of hypertension. The guidelines are not mandatory, and members of the task force fully realize that treatment of hypertension should be individualized to address each patient's circumstances. Ultimately, the decision of the physician decision remains of the utmost importance in hypertension management

Comparisons of clinical impacts on individuals with Brugada electrocardiographic patterns defined by ISHNE criteria or EHRA/HRS/APHRS criteria: a nationwide community-based study

<p><b>Introduction:</b> Identifying Brugada electrocardiographic pattern (BrP) early is crucial to prevent sudden cardiac death. Two different diagnostic criteria proposed by International Society for Holter and Noninvasive Electrocardiography (ISHNE) and Heart Rhythm Society/European Heart Rhythm Association/Asia-Pacific Heart Rhythm Society (HRS/EHRA/APHRS) were widely used in clinical practice. The difference in prevalence and prognosis of BrP by applying the two different criteria was never studied before.</p> <p><b>Methods:</b> This study was prospectively conducted in a nationwide large-scale stratified random sampling community-based cohort (HALST) from Han Chinese population in Taiwan from December 2008 to December 2012. We compared the prevalence and prognosis of BrP defined by the two diagnostic criteria.</p> <p><b>Results:</b> A total of 5214 adults were enrolled (2530 men) with mean age of 69.3 years. Four had spontaneous type 1 BrP (0.077%). By the HRS/EHRA/APHRS criteria, 68 individuals have type 2 BrP (1.30%) and 101 have type 3 BrP (1.94%) whereas by the ISHNE criteria, 46 individuals exhibited type 2 BrP (0.88%). When applying the ISHNE criteria, the number of individuals with BrP decreased by 71%. However, all-cause mortality and cardiovascular mortality were not different between individuals with or without BrP, irrespective of the criteria used.</p> <p><b>Conclusions:</b> The two different criteria may impact the diagnostic yield of individuals with BrP, but do not affect the prognosis of the individuals with BrP.Key messages</p><p>Comparing with the use of HRS/EHRA/APHRS criteria, the number of individuals with Brugada ECG patterns was decreased by 71% when applying the ISHNE criteria.</p><p>The prognosis of individuals with Brugada ECG patterns defined by 2012 ISHNE or 2013 HRS/EHRA/APHRS criteria were not different.</p><p></p> <p>Comparing with the use of HRS/EHRA/APHRS criteria, the number of individuals with Brugada ECG patterns was decreased by 71% when applying the ISHNE criteria.</p> <p>The prognosis of individuals with Brugada ECG patterns defined by 2012 ISHNE or 2013 HRS/EHRA/APHRS criteria were not different.</p

Comparisons of clinical impacts on individuals with Brugada electrocardiographic patterns defined by ISHNE criteria or EHRA/HRS/APHRS criteria: A nationwide community-based study

[[abstract]]INTRODUCTION: Identifying Brugada electrocardiographic pattern (BrP) early is crucial to prevent sudden cardiac death. Two different diagnostic criteria proposed by International Society for Holter and Noninvasive Electrocardiography (ISHNE) and Heart Rhythm Society/European Heart Rhythm Association/Asia-Pacific Heart Rhythm Society (HRS/EHRA/APHRS) were widely used in clinical practice. The difference in prevalence and prognosis of BrP by applying the two different criteria was never studied before. METHODS: This study was prospectively conducted in a nationwide large-scale stratified random sampling community-based cohort (HALST) from Han Chinese population in Taiwan from December 2008 to December 2012. We compared the prevalence and prognosis of BrP defined by the two diagnostic criteria. RESULTS: A total of 5214 adults were enrolled (2530 men) with mean age of 69.3 years. Four had spontaneous type 1 BrP (0.077%). By the HRS/EHRA/APHRS criteria, 68 individuals have type 2 BrP (1.30%) and 101 have type 3 BrP (1.94%) whereas by the ISHNE criteria, 46 individuals exhibited type 2 BrP (0.88%). When applying the ISHNE criteria, the number of individuals with BrP decreased by 71%. However, all-cause mortality and cardiovascular mortality were not different between individuals with or without BrP, irrespective of the criteria used. CONCLUSIONS: The two different criteria may impact the diagnostic yield of individuals with BrP, but do not affect the prognosis of the individuals with BrP. Key messages Comparing with the use of HRS/EHRA/APHRS criteria, the number of individuals with Brugada ECG patterns was decreased by 71% when applying the ISHNE criteria. The prognosis of individuals with Brugada ECG patterns defined by 2012 ISHNE or 2013 HRS/EHRA/APHRS criteria were not different